BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zong J, Fan Z, Zhang Y. Serum Tumor Markers for Early Diagnosis of Primary Hepatocellular Carcinoma. J Hepatocell Carcinoma 2020;7:413-22. [PMID: 33376710 DOI: 10.2147/JHC.S272762] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Hu X, He Y, Han Z, Liu W, Liu D, Zhang X, Chen L, Qi L, Chen L, Luo Y, Li Q, Chen P, Wu Q, Zhu X, Guo H. PNO1 inhibits autophagy-mediated ferroptosis by GSH metabolic reprogramming in hepatocellular carcinoma. Cell Death Dis 2022;13:1010. [PMID: 36446769 DOI: 10.1038/s41419-022-05448-7] [Reference Citation Analysis]
2 Li L, Ma B, Liu F, Sheng C, Peng Y, Qiao Y, Wang P, Chen K, Song F. The Number of Positive Tumor Markers (NPTM) Achieves Higher Value in the Prognosis Prediction of Gastric Cancer. Disease Markers 2022;2022:1-13. [DOI: 10.1155/2022/5145918] [Reference Citation Analysis]
3 Moudi B, Mohades M, Mahmoudzadeh-sagheb H, Heidari Z. Immunohistochemical expression of CB1 receptors in the liver of patients with HBV related-HCC. Arab Journal of Gastroenterology 2022. [DOI: 10.1016/j.ajg.2022.10.002] [Reference Citation Analysis]
4 Deng PZ, Zhao BG, Huang XH, Xu TF, Chen ZJ, Wei QF, Liu XY, Guo YQ, Yuan SG, Liao WJ. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma. World J Gastroenterol 2022; 28(31): 4376-4389 [DOI: 10.3748/wjg.v28.i31.4376] [Reference Citation Analysis]
5 Zhang H, Du X, Dong H, Xu W, Zhou P, Liu S, Qing X, Zhang Y, Yang M, Zhang Y. Risk factors and predictive nomograms for early death of patients with advanced hepatocellular carcinoma: a large retrospective study based on the SEER database. BMC Gastroenterol 2022;22:348. [PMID: 35854221 DOI: 10.1186/s12876-022-02424-5] [Reference Citation Analysis]
6 Zhao D, Cao J, Zhang L, Zhang S, Wu S. Targeted Molecular Imaging Probes Based on Magnetic Resonance Imaging for Hepatocellular Carcinoma Diagnosis and Treatment. Biosensors 2022;12:342. [DOI: 10.3390/bios12050342] [Reference Citation Analysis]
7 Wei C, Wang B, Chen ZH, Xiao H, Tang L, Guan JF, Yuan RF, Yu X, Hu ZG, Wu HJ, Dai Z, Wang K. Validating RRP12 Expression and Its Prognostic Significance in HCC Based on Data Mining and Bioinformatics Methods. Front Oncol 2022;12:812009. [PMID: 35178347 DOI: 10.3389/fonc.2022.812009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Chen Y, Zhang J, Liu J, Wang J, Shi C, Lu L, Cheng X, Niu G, Zhang S, Cui D. The Expression and Clinical Significance of PCNAP1 in Hepatocellular Carcinoma Patients. Journal of Immunology Research 2022;2022:1-7. [DOI: 10.1155/2022/1817694] [Reference Citation Analysis]
9 Li J, Zhao S, Ling Z, Li D, Jia G, Zhao C, Lin X, Dai Y, Jiang H, Wang S, Teekaraman Y. Dual-Energy Computed Tomography Imaging in Early-Stage Hepatocellular Carcinoma: A Preliminary Study. Contrast Media & Molecular Imaging 2022;2022:1-8. [DOI: 10.1155/2022/2146343] [Reference Citation Analysis]
10 Pappu P, Vijay U, Madduru D, Stephen NB, Suravajhala P, Bandapalli OR. Conventional and novel biomarkers for the diagnosis and prognosis of liver cancer. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2 2022. [DOI: 10.1016/b978-0-323-98807-0.00005-3] [Reference Citation Analysis]
11 Chalikonda G, Allen S, Vadde R, Nagaraju GP. Hepatocellular carcinoma diagnosis. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2 2022. [DOI: 10.1016/b978-0-323-98807-0.00008-9] [Reference Citation Analysis]
12 Xu Y, Guo Q, Wei L. The Emerging Influences of Alpha-Fetoprotein in the Tumorigenesis and Progression of Hepatocellular Carcinoma. Cancers (Basel) 2021;13:5096. [PMID: 34680245 DOI: 10.3390/cancers13205096] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]